207 20162 59 dating


16-Nov-2017 00:44

Evidence of a system in crisis commands the country’s media and political attention, and of course data contribute integrally to the debate.One testimony – an NHS cataloguing of hospital treatment waiting times distributed by hospital and medical specialty – is here: download-waiting-times-by-hospital-trust-xls-6289k-nov16-17215 The workbook’s front end comprises a Report tab, whose dropdown menus synopsize patient waiting time data for any user-selected hospital and treatment area. (1997) Studies of water and electrolyte movement from oral rehydration solutions (rice- and glucose-based) across a normal and secreting gut using a dual isotope tracer technique in a rat perfusion model. (1997) Tyrosine phosphorylation mediates Con A-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells. (1997) The mammalian protein (rbet1) homologous to yeast Bet1p is primarily associated with the pre-Golgi intermediate compartment and is involved in vesicular transport from the endoplasmic reticulum to the Golgi apparatus. An investigation into family awareness and use of literacy resources available in the community and school: Report on a research project undertaken by QUT in collaboration with Kruger and Carole Park State Schools. (1997) Investigations of Rotation of Axial Ligands in Six-Coordinate Low-Spin Iron(III) Tetraphenylporphyrinates: Measurement of Rate Constants from Saturation Transfer Experiments and Comparison to Molecular Mechanics Calculations. Machine learning, neural networks and information security : techniques for extracting rules from trained feedforward Artificial Neural Networks and their application in an information security problem domain.Those 20 aggregating rows loose a familiar complication upon the data sets, at for the pivot tablers among you.

207 20162 59 dating-23

Live sexs chat webcam

Our data also have important implications for the hosts of He in long-traveled dust and for the He ratio used for terrigenous He in studies of extraterrestrial He in sediments and ice.You may want to trace the contributory formulas, and note the lookups performed by the OFFSET function, about which we hope to say a bit more a bit later.Note as well the section topped by the Patients Waiting to Start Treatment reference data, vested in the Incomp Prov sheet; information about patients who completed their what the NHS terms their pathway and started treatment is displayed by the two recaps that follow, the first keyed to the Adm Prov sheet, the second to Non Adm Prov.The invention provides non-naturally occurring microbial organisms containing 2,4-pentadienoate, butadiene, propylene, 1,3-butanediol, crotyl alcohol or 3-buten-1-ol pathways comprising at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce 2,4-pentadienoate, butadiene, propylene, 1,3-butanediol, crotyl alcohol or 3-buten-1-ol.

The invention additionally provides methods of using such microbial organisms to produce 2,4-pentadienoate, butadiene, propylene, 1,3-butanediol, crotyl alcohol or 3-buten-1-ol, by culturing a non-naturally occurring microbial organism containing 2,4-pentadienoate, butadiene, propylene, 1,3-butanediol, crotyl alcohol or 3-buten-1-ol pathways as described herein under conditions and for a sufficient period of time to produce 2,4-pentadienoate, butadiene, propylene, 1,3-butanediol, crotyl alcohol or 3-buten-1-ol. A non-naturally occurring microbial organism, comprising a microbial organism having a 1,3-butanediol pathway comprising at least one exogenous nucleic acid encoding a 1,3-butanediol pathway enzyme expressed in a sufficient amount to produce 1,3-butanediol, wherein said 1,3-butanediol pathway comprises a pathway selected from: wherein 4A is a 3-oxo-5-hydroxypentanoyl-Co A thiolase or a 3-oxo-5-hydroxypentanoyl-Co A synthase, wherein 4B is a 3-oxo-5-hydroxypentanoyl-Co A hydrolase, 3-oxo-5-hydroxypentanoyl-Co A transferase or 3-oxo-5-hydroxypentanoyl-Co A synthetase, wherein 4C is a 3-oxo-5-hydroxypentanoate decarboxylase, wherein 4D is a 3-oxobutanol reductase, wherein in 5A is a 4-hydroxy-2-oxovalerate aldolase, wherein 5F is a 4-hydroxy-2-oxovalerate decarboxylase, wherein 5G is a 3-hydroxybutanal reductase, wherein 5H is a 4-hydroxy-2-oxopentanoate dehydrogenase, a 4-hydroxy-2-oxopentanoate:ferredoxin oxidoreductase or a 4-hydroxy-2-oxopentanoate formate lyase, wherein 51 is a 3-hydroxybutyryl-Co A reductase (aldehyde forming), wherein 5J is a 3-hydroxybutyryl-Co A hydrolase, a 3-hydroxybutyryl-Co A transferase or a 3-hydroxybutyryl-Co A synthetase, wherein 5K is a 3-hydroxybutyrate reductase, wherein 5L is a 3-hydroxybutyryl-Co A reductase (alcohol forming), wherein 7A is a 3-ketoacyl-ACP synthase, wherein 7B is an acetoacetyl-ACP reductase, wherein 7D is an acetoacetyl-Co A: ACP transferase, wherein 7E is an acetoacetyl-Co A hydrolase, acetoacetyl-Co A transferase or acetoacetyl-Co A synthetase, wherein 7F is an acetoacetate reductase (acid reducing), wherein 7G is a 3-oxobutyraldehyde reductase (aldehyde reducing), wherein 7H is an acetoacetyl-ACP thioesterase, wherein 7I is an acetoacetyl-Co A reductase (Co A-dependent, aldehyde forming), wherein 7J is an acetoacetyl-ACP reductase (aldehyde forming), wherein 7K is an acetoacetyl-Co A reductase (alcohol forming), wherein 7L is a 3-hydroxybutyryl-ACP thioesterase, wherein 7M is a 3-hydroxybutyryl-ACP reductase (aldehyde forming), wherein 7N is a 3-hydroxybutyryl-Co A reductase (aldehyde forming), wherein 7O is a 3-hydroxybutyryl-Co A reductase (alcohol forming), wherein 7P is an acetoacetyl-Co A reductase (ketone reducing), wherein 7Q is an acetoacetate reductase (ketone reducing), wherein 7R is a 3-oxobutyraldehyde reductase (ketone reducing), wherein 7S is a 4-hydroxy-2-butanone reductase, wherein 7X is a 3-hydroxybutyryl-Co A: ACP transferase, wherein 7Y is a 3-hydroxybutyryl-Co A hydrolase, a 3-hydroxybutyryl-Co A transferase or a 3-hydroxybutyryl-Co A synthetase, wherein 7Z is a 3-hydroxybutyrate reductase, wherein 7AA is a 3-hydroxybutyraldehyde reductase and wherein 7AS is an acetoacetyl-Co A synthase. A non-naturally occurring microbial organism, comprising a microbial organism having a 2,4-pentadienoate pathway comprising at least one exogenous nucleic acid encoding a 2,4-pentadienoate pathway enzyme expressed in a sufficient amount to produce 2,4-pentadienoate, wherein said 2,4-pentadienoate pathway comprises a pathway selected from: wherein 1B is a 5-aminopentanoate reductase, wherein 1C is a 5-aminopent-2-enoate aminotransferase, a 5-aminopent-2-enoate dehydrogenase or an amine oxidase, wherein 1D is a 2-oxoadipate decarboxylase, wherein 1E is a glutarate semialdehyde reductase, wherein 1F is a 5-hydroxyvalerate dehydrogenase, wherein 1G is a 5-hydroxypent-2-enoate dehydratase, wherein 1I is a 5-aminopentanoate aminotransferase, a 5-aminopentanoate dehydrogenase or a 5-aminopentanoate amine oxidase, wherein 1J is a 5-aminopent-2-enoate deaminase, wherein 1K is a 5-hydroxypent-2-enoate reductase, wherein 1L is a 5-hydroxyvaleryl-Co A transferase or a 5-hydroxyvaleryl-Co A synthetase, wherein 1M is a 5-hydroxypentanoyl-Co A dehydrogenase, wherein 1N is a 5-hydroxypent-2-enoyl-Co A dehydratase, wherein 1O is a 2,4-pentadienoyl-Co A transferase, a 2,4-pentadienoyl-Co A synthetase or a 2,4-pentadienoyl-Co A hydrolase, wherein 1P is a 5-hydroxypent-2-enoyl-Co A transferase or a 5-hydroxypent-2-enoyl-Co A synthetase, wherein 1Q is a 5-hydroxyvaleryl-Co A dehydratase/dehydrogenase, wherein 1S a glutaryl-Co A reductase, wherein 3A is a 3-oxopentanoyl-Co A thiolase or a 3-oxopentanoyl-Co A synthase, wherein 3B is a 3-oxopentanoyl-Co A reductase, wherein 3C is a 3-hydroxypentanoyl-Co A dehydratase, wherein 3D is a pent-2-enoyl-Co A isomerase, wherein 3E is a pent-3-enoyl-Co A dehydrogenase, wherein 3F is a 2,4-pentadienoyl-Co A hydrolase, a 2,4-pentadienoyl-Co A transferase or a 2,4-pentadienoyl-Co A synthetase, wherein 3G is a pent-2-enoyl-Co A dehydrogenase. A non-naturally occurring microbial organism, comprising a microbial organism having a butadiene pathway comprising at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce butadiene, wherein said butadiene pathway comprises a pathway selected from: wherein 1B is a 5-aminopentanoate reductase, a 5-aminopent-2-enoate aminotransferase, a 5-aminopent-2-enoate dehydrogenase or 5-aminopent-2-enoate amine oxidase, wherein 1D is a 2-oxoadipate decarboxylase, wherein 1E is a glutarate semialdehyde reductase, wherein 1F is a 5-hydroxyvalerate reductase, wherein 1G is a 5-hydroxypent-2-enoate dehydratase, wherein 1I is a 5-aminopentanoate aminotransferase, a 5-aminopentanoate dehydrogenase or a 5-aminopentanoate amine oxidase, wherein 1J is a 5-aminopent-4-enoate deaminase, wherein 1K is a 5-hydroxypent-2-enoate reductase, wherein 1L is a 5-hydroxyvaleryl-Co A transferase or a 5-hydroxyvaleryl-Co A synthetase, wherein 1M is a 5-hydroxypentanoyl-Co A dehydrogenase, wherein 1N is a 5-hydroxypent-2-enoyl-Co A dehydratase, wherein 1O is a 2,4-pentadienoyl-Co A transferase, a 2,4-pentadienoyl-Co A synthetase or a 2,4-pentadienoyl-Co A hydrolase, wherein 1P is a 5-hydroxypent-2-enoyl-Co A transferase or a 5-hydroxypent-2-enoyl-Co A synthetase, wherein in 1Q is a 5-hydroxyvaleryl-Co A dehydratase/dehydrogenase, wherein 1S is a glutaryl-Co A reductase, wherein 1T is a 2,4-pentadienoate decarboxylase, wherein 1U is a 5-hydroxypent-2-enoate decarboxylase, wherein 1V is a 3-buten-1-ol dehydratase, wherein 1W is a 5-hydroxyvalerate decarboxylase, wherein 3A is a 3-oxopentanoyl-Co A thiolase or a 3-oxopentanoyl-Co A synthase, wherein 3B is a 3-oxopentanoyl-Co A reductase, wherein 3C is a 3-hydroxypentanoyl-Co A dehydratase, wherein 3D is a pent-2-enoyl-Co A isomerase, wherein 3E is a pent-3-enoyl-Co A dehydrogenase, wherein 3F is a 2,4-pentadienoyl-Co A hydrolase, a 2,4-pentadienoyl-Co A transferase or a 2,4-pentadienoyl-Co A synthetase, wherein 3G is a pent-2-enoyl-Co A dehydrogenase, wherein 5A is a 4-hydroxy-2-oxovalerate aldolase, wherein 5B is a 4-hydroxy-2-oxovalerate dehydratase, wherein 5C is a 2-oxopentenoate decarboxylase, wherein 5D is a 3-buten-1-al reductase, wherein 5E is a 3-buten-1-ol dehydratase, wherein 6A is a 2,4-pentadienoate reductase (acid reducing), wherein 6B is a penta-2,4-dienal decarbonylase, wherein 6C is a 2,4-pentadienoyl-Co A reductase (acid reducing), wherein 6D is a 2,4-pentadienoyl-Co A phosphotransferase, wherein 6E is a 2,4-pentadienoyl-phosphate reductase, wherein 6F is a 2,4-pentadienoyl-Co A hydrolase, a 2,4-pentadienoyl-Co A transferase or a 2,4-pentadienoyl-Co A synthetase, wherein 6H is a 2,4-pentadienoate kinase, wherein 7A is a 3-ketoacyl-ACP synthase, wherein 7B is an acetoacetyl-ACP reductase, wherein 7C is a 3-hydroxybutyryl-ACP dehydratase, wherein 7D is an acetoacetyl-Co A: ACP transferase, wherein 7E is an acetoacetyl-Co A hydrolase, an acetoacetyl-Co A transferase or an acetoacetyl-Co A synthetase, wherein 7F is an acetoacetate reductase (acid reducing), wherein 7H is an acetoacetyl-ACP thioesterase, wherein 7I is an acetoacetyl-Co A reductase (Co A-dependent, aldehyde forming), wherein 7J is an acetoacetyl-ACP reductase (aldehyde forming), wherein 7K is an acetoacetyl-Co A reductase (alcohol forming), wherein 7L is an 3-hydroxybutyryl-ACP thioesterase, wherein 7M is an 3-hydroxybutyryl-ACP reductase (aldehyde forming), wherein 7N is an 3-hydroxybutyryl-Co A reductase (aldehyde forming), wherein 7O is an 3-hydroxybutyryl-Co A reductase (alcohol forming), wherein 7P is an acetoacetyl-Co A reductase (ketone reducing), wherein 7Q is an acetoacetate reductase (ketone reducing), wherein 7R is a 3-oxobutyraldehyde reductase (ketone reducing), wherein 7T is a crotonyl-ACP thioesterase, wherein 7U is a crotonyl-ACP reductase (aldehyde forming), wherein 7V is a crotonyl-Co A reductase (aldehyde forming), wherein 7W is a crotonyl-Co A (alcohol forming), wherein 7X is a 3-hydroxybutyryl-Co A: ACP transferase, wherein 7Y is a 3-hydroxybutyryl-Co A hydrolase, a 3-hydroxybutyryl-Co A transferase or a 3-hydroxybutyryl-Co A synthetase, wherein 7Z is a 3-hydroxybutyrate reductase, wherein 7AB is a 3-hydroxybutyryl-Co A dehydratase, wherein 7AC is a 3-hydroxybutyrate dehydratase, wherein 7AD is a 3-hydroxybutyraldehyde dehydratase, wherein 7AE is a crotonyl-Co A: ACP transferase, wherein 7AF is a crotonyl-Co A hydrolase, a crotonyl-Co A transferase or a crotonyl-Co A synthetase, wherein 7AG is a crotonate reductase, wherein 7AH is a crotonaldehyde reductase, wherein 7AS is an acetoacetyl-Co A synthase, wherein 12A is a crotyl alcohol kinase, wherein 12B is a 2-butenyl-4-phosphate kinase, wherein 12C is a butadiene synthase, and wherein 12D is a crotyl alcohol diphosphokinase.(43)-(79), wherein said microbial organism further comprises a glutaryl-Co A pathway comprising at least one exogenous nucleic acid encoding a glutaryl-Co A pathway enzyme expressed in a sufficient amount to produce glutaryl-Co A, said glutaryl-Co A pathway comprising a pathway selected from:a 2-aminoadipate aminotransferase, a 2-aminoadipate dehydrogenase or a 2-amininoadipate amine oxidase; and a 2-oxoadipate dehydrogenase, a 2-oxoadipate:ferridoxin oxidoreductase or a 2-oxoadipate formate lyase,(80)-(116), wherein said microbial organism further comprises a 5-aminopentanoate pathway comprising at least one exogenous nucleic acid encoding a 5-aminopentanoate pathway enzyme expressed in a sufficient amount to produce 5-aminopentanoate, said 5-aminopentanoate pathway comprising a 2-aminoadipate decarboxylase; or a 2-aminoadipate decarboxylase and a 2-aminoadipate aminotransferase, a 2-aminoadipate dehydrogenase or a 2-aminoadipate amine oxidase, and(1)-(42), wherein said microbial organism further comprises a 2-oxoadipate pathway comprising an exogenous nucleic acid encoding a 2-oxoadipate pathway enzyme expressed in a sufficient amount to produce a 2-oxoadipate, said 2-oxoadipate pathway comprising a 2-aminoadipate aminotransferase, a 2-aminoadipate dehydrogenase or a 2-aminoadipate amine oxidase. A non-naturally occurring microbial organism, comprising a microbial organism having a 3-buten-1-ol pathway comprising at least one exogenous nucleic acid encoding a 3-buten-1-ol pathway enzyme expressed in a sufficient amount to produce 3-buten-1-ol, wherein said 3-buten-1-ol pathway comprises a pathway selected from: wherein 1B is a 5-aminopentanoate reductase, wherein 1C is a 5-aminopent-2-enoate aminotransferase, a 5-aminopent-2-enoate dehydrogenase or an amine oxidase, wherein 1D is a 2-oxoadipate decarboxylase, wherein 1E is a glutarate semialdehyde reductase, wherein 1F is a 5-hydroxyvalerate dehydrogenase, wherein 1I is a 5-aminopentanoate aminotransferase, a 5-aminopentanoate dehydrogenase or a 5-aminopentanoate amine oxidase, wherein 1K is a 5-hydroxypent-2-enoate reductase, wherein 1L is a 5-hydroxyvaleryl-Co A transferase or a 5-hydroxyvaleryl-Co A synthetase, wherein 1M is a 5-hydroxypentanoyl-Co A dehydrogenase, wherein 1P is a 5-hydroxypent-2-enoyl-Co A transferase or a 5-hydroxypent-2-enoyl-Co A synthetase, wherein 1S is a glutaryl-Co A reductase, wherein 1U is a 5-hydroxypent-2-enoate decarboxylase, wherein 1W is a 5-hydroxyvalerate decarboxylase, wherein 5A is a 4-hydroxy-2-oxovalerate aldolase, wherein 5B is a 4-hydroxy-2-oxovalerate dehydratase, wherein 5C is a 2-oxopentenoate decarboxylase, wherein 5D is a 3-buten-1-al reductase. A non-naturally occurring microbial organism, comprising a microbial organism having a crotyl alcohol pathway comprising at least one exogenous nucleic acid encoding a crotyl alcohol pathway enzyme expressed in a sufficient amount to produce crotyl alcohol, wherein said crotyl alcohol pathway comprises a pathway selected from: wherein 7A is a 3-ketoacyl-ACP synthase, wherein 7B is an acetoacetyl-ACP reductase, wherein 7C is a 3-hydroxybutyryl-ACP dehydratase, wherein 7D is an acetoacetyl-Co A: ACP transferase, wherein 7E is an acetoacetyl-Co A hydrolase, an acetoacetyl-Co A transferase or an acetoacetyl-Co A synthetase, wherein 7F is an acetoacetate reductase (acid reducing), wherein 7H is an acetoacetyl-ACP thioesterase, wherein 7I is an acetoacetyl-Co A reductase (Co A-dependent, aldehyde forming), wherein 7J is an acetoacetyl-ACP reductase (aldehyde forming), wherein 7K is an acetoacetyl-Co A reductase (alcohol forming), wherein 7L is an 3-hydroxybutyryl-ACP thioesterase, wherein 7M is an 3-hydroxybutyryl-ACP reductase (aldehyde forming), wherein 7N is an 3-hydroxybutyryl-Co A reductase (aldehyde forming), wherein 7O is an 3-hydroxybutyryl-Co A reductase (alcohol forming), wherein 7P is an acetoacetyl-Co A reductase (ketone reducing), wherein 7Q is an acetoacetate reductase (ketone reducing), wherein 7R is a 3-oxobutyraldehyde reductase (ketone reducing), wherein 7T is a crotonyl-ACP thioesterase, wherein 7U is a crotonyl-ACP reductase (aldehyde forming), wherein 7V is a crotonyl-Co A reductase (aldehyde forming), wherein 7W is a crotonyl-Co A (alcohol forming), wherein 7X is a 3-hydroxybutyryl-Co A: ACP transferase, wherein 7Y is a 3-hydroxybutyryl-Co A hydrolase, a 3-hydroxybutyryl-Co A transferase or a 3-hydroxybutyryl-Co A synthetase, wherein 7Z is a 3-hydroxybutyrate reductase, wherein 7AB is a 3-hydroxybutyryl-Co A dehydratase, wherein 7AC is a 3-hydroxybutyrate dehydratase, wherein 7AD is a 3-hydroxybutyraldehyde dehydratase, wherein 7AE is a crotonyl-Co A: ACP transferase, wherein 7AF is a crotonyl-Co A hydrolase, a crotonyl-Co A transferase or a crotonyl-Co A synthetase, wherein 7AG is a crotonate reductase, wherein 7AH is a crotonaldehyde reductase and wherein 7AS is an acetoacetyl-Co A synthase. A non-naturally occurring microbial organism, comprising a microbial organism having a propylene pathway comprising at least one exogenous nucleic acid encoding a propylene pathway enzyme expressed in a sufficient amount to produce propylene, wherein said propylene pathway comprises a pathway selected from: wherein 7A is a 3-ketoacyl-ACP synthase, wherein 7B is an acetoacetyl-ACP reductase, wherein 7C is a 3-hydroxybutyryl-ACP dehydratase, wherein 7D is an acetoacetyl-Co A: ACP transferase, wherein 7E is an acetoacetyl-Co A hydrolase, an acetoacetyl-Co A transferase or an acetoacetyl-Co A synthetase, wherein 7F is an acetoacetate reductase (acid reducing), wherein 7H is an acetoacetyl-ACP thioesterase, wherein 7I is an acetoacetyl-Co A reductase (Co A-dependent, aldehyde forming), wherein 7J is an acetoacetyl-ACP reductase (aldehyde forming), wherein 7L is a 3-hydroxybutyryl-ACP thioesterase, wherein 7M is a 3-hydroxybutyryl-ACP reductase (aldehyde forming), wherein 7N is a 3-hydroxybutyryl-Co A reductase (aldehyde forming), wherein 7P is an acetoacetyl-Co A reductase (ketone reducing), wherein 7Q is an acetoacetate reductase (ketone reducing), wherein 7R is a 3-oxobutyraldehyde reductase (ketone reducing), wherein 7S is a 4-hydroxy-2-butanone reductase, wherein 7T is a crotonyl-ACP thioesterase, wherein 7U is a crotonyl-ACP reductase (aldehyde forming), wherein 7V is a crotonyl-Co A reductase (aldehyde forming), wherein 7X is a 3-hydroxybutyryl-Co A: ACP transferase, wherein 7Y is a 3-hydroxybutyryl-Co A hydrolase, a 3-hydroxybutyryl-Co A transferase or a 3-hydroxybutyryl-Co A synthetase, wherein 7Z is a 3-hydroxybutyrate reductase, wherein 7AB is a 3-hydroxybutyryl-Co A dehydratase, wherein 7AC is a 3-hydroxybutyrate dehydratase, wherein 7AD is a 3-hydroxybutyraldehyde dehydratase, wherein 7AE is a crotonyl-Co A: ACP transferase, wherein 7AF is a crotonyl-Co A hydrolase, a crotonyl-Co A transferase or a crotonyl-Co A synthetase, wherein 7AG is a crotonate reductase, wherein 7AI is a butryl-Co A: ACP transferase, wherein 7AJ is a butyryl-Co A transferase, a butyryl-Co A hydrolase or a butyryl-Co A synthetase, wherein 7AK is a butyrate decarboxylase, wherein 7AL is a crotonyl-ACP reductase, wherein 7AM is a crotonyl-Co A reductase, wherein 7AN is a crotonate reductase, wherein 7AO is a crotonaldehyde decarbonylase, wherein 7AP is a butyryl-ACP thioesterase, wherein 7AQ is a crotonate decarboxylase, wherein 7AR is a 3-hydroxybutyrate decarboxylase and wherein 7AS is an acetoacetyl-Co A synthase.

More recently, dust fluxes have been estimated from measurements of helium and thorium, as rare isotopes of these elements (He-3 and Th-230) allow estimates of sediment flux, and the dominant isotopes (He-4 and Th-232) are uniquely associated with the lithogenic fraction of marine sediments.